Today: 16 April 2026
Legence (LGN) stock drops nearly 9% today as contractors slide ahead of U.S. payrolls
8 January 2026
1 min read

Legence (LGN) stock drops nearly 9% today as contractors slide ahead of U.S. payrolls

New York, Jan 8, 2026, 14:38 EST — Regular session

  • Legence shares slid about 9% in afternoon trading, reversing an early move higher
  • Contractor peers also fell, while Wall Street traded mixed ahead of key U.S. jobs data
  • Traders are watching Friday’s payrolls report and any further deal-related filings from Legence

Legence Corp (LGN.O) shares fell about 9% to $43.99 on Thursday, after earlier touching $48.79. The stock closed at $48.32 on Wednesday.

The pullback lands on a newly public name that has moved fast since its September debut. Blackstone-backed Legence raised $728 million in an IPO priced at $28 a share and sells engineering and maintenance work for building systems, including heating and air conditioning.

Broader markets offered little shelter. Wall Street was mixed on Thursday and traders focused on Friday’s nonfarm payrolls report for December, with technology shares weighing on the Nasdaq.

Other construction and engineering stocks were also lower: Comfort Systems USA was down about 7%, EMCOR about 5% and Quanta Services about 6%. Legence traded as low as $43.67 and volume topped 600,000 shares.

The company’s last major update came on Jan. 2, when it said it completed its acquisition of The Bowers Group, paying $325 million in cash and issuing about 2.55 million shares. Chief Executive Jeff Sprau called it “an important milestone in our growth strategy.” Legence

A regulatory filing showed Legence funded the cash portion with a mix that included a $200 million incremental term loan facility that it drew in full at closing. A term loan is long-term borrowing; the company said the incremental loans carry terms identical to its existing term debt and it expects to file deal financials and pro forma information within 71 days.

At its last quarterly report in November, Legence forecast 2026 revenue of $2.65 billion to $2.85 billion and adjusted EBITDA of $295 million to $315 million. Adjusted EBITDA is a non-GAAP profit gauge that backs out items like interest, taxes and depreciation to give a cleaner view of operating performance.

Thursday’s slide also took the shares back below $45, the price used in an upsized secondary offering by selling stockholders in December. The prospectus said Legence did not sell any shares in that deal and would not receive proceeds, and it warned that future stock sales could pressure the share price.

But big swings cut both ways for a fresh IPO with an acquisition and new borrowing in the mix. A hotter-than-expected jobs report could keep rate worries alive, and any stumble in integrating recent deals could hit margins.

Stock Market Today

  • Corn Futures Slide Amid Mixed Export Sales and Higher Global Production Forecast
    April 16, 2026, 3:32 PM EDT. Corn futures declined by up to 3 ¼ cents on Thursday after initial gains earlier in the session. The weekly U.S. Export Sales report showed old crop corn sales of 120,477 metric tonnes (MT), below estimates, while new crop sales reached 800,518 MT, exceeding expectations. Notably, 345,000 MT were sold to unknown buyers; Mexican importers accounted for 257,900 MT. The International Grains Council raised its world corn production estimate by 1 million MT to 1.226 billion MT but also cut stock estimates by 1 million MT to 277 million MT. September 2024 corn futures closed at $3.7775, down 3.25 cents. Prices across nearby and new crop contracts also edged lower amid these mixed signals influencing the market.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
ICON stock sinks nearly 8% after Truist downgrade puts 2026 outlook in the spotlight
Previous Story

ICON stock sinks nearly 8% after Truist downgrade puts 2026 outlook in the spotlight

Qualcomm stock rises as Volkswagen lines up long-term Snapdragon infotainment deal
Next Story

Qualcomm stock rises as Volkswagen lines up long-term Snapdragon infotainment deal

Go toTop